scleroderma
Showing 726 - 743 of 743
Systemic Scleroderma, Skin Fibrosis, Hand Functionality Trial in Duesseldorf (Bosentan (Tracleer))
Completed
- Systemic Scleroderma
- +2 more
- Bosentan (Tracleer)
-
Duesseldorf, NRW, GermanyHeinrich-Heine-University of Duesseldorf, Department of Dermatol
Sep 7, 2007
L-5-HTP-Related EMS
Completed
- Eosinophilia-Myalgia Syndrome
-
Bethesda, MarylandNational Institute of Mental Health (NIMH)
Mar 3, 2008
Raynaud's Disease, Raynaud's Disease Secondary to Scleroderma, Raynaud's Disease Secondary to Autoimmune Disease Trial in Renton
Completed
- Raynaud's Disease
- +2 more
-
Renton, WashingtonRainier Clinical Research
May 29, 2007
Scleroderma, Systemic Trial in Ancona (Platelet Gel)
Unknown status
- Scleroderma, Systemic
- Platelet Gel
-
Ancona, ItalyUniversità politecnica delle marche
Apr 19, 2007
Raynaud Disease, Raynaud Disease Secondary to Scleroderma, Raynaud Secondary to Other Autoimmune Disease Trial in Baltimore,
Completed
- Raynaud Disease
- +2 more
- topical organogel with nitroglycerin
-
Baltimore, Maryland
- +1 more
May 29, 2007
Non-Invasive Diagnostic and Functional Evaluation of Cardiac
Unknown status
- Systemic Sclerosis
-
Warsaw, Lindleya 4, PolandMichał Ciurzyński
Mar 28, 2007
Pulmonary Hypertension Trial in Houston (sitaxsentan sodium)
Completed
- Pulmonary Hypertension
- sitaxsentan sodium
-
Houston, TexasEncysive Pharmaceuticals
Nov 8, 2007
Raynaud's Disease Trial in Canada, United States (Topical organogel with nitroglycerin)
Completed
- Raynaud's Disease
- Topical organogel with nitroglycerin
-
Stanford, California
- +18 more
Aug 6, 2007
Raynaud's Disease, Scleroderma, Autoimmune Diseases Trial in Sweden, United Kingdom, United States (Topical AmphiMatrix with
Completed
- Raynaud's Disease
- +2 more
- Topical AmphiMatrix with nitroglycerin (MQX-503)
-
Stanford, California
- +11 more
May 29, 2007
Scleroderma, Diffuse Trial in Italy (N-acetylcysteine (NAC))
Unknown status
- Scleroderma, Diffuse
- N-acetylcysteine (NAC)
-
Ancona, Italy
- +4 more
Jan 29, 2007
Coronary Artery Disease, Inflammatory Response, Atherosclerosis Trial in Willoughby Hills (eicosapentaenoic acid (EPA),)
Terminated
- Coronary Artery Disease
- +2 more
- eicosapentaenoic acid (EPA),
-
Willoughby Hills, OhioCleveland Clinic Willoughby Hills Family Health Center
Dec 19, 2007
CTGF Protein and Related Cytokine in Pleural Effusion
Unknown status
- Tuberculosis
- +3 more
-
Taichung, Taiwan, ChinaDivision of Chest Medicine, Department of Internal Medicine, Tai
Apr 9, 2006
FBN1 Gene and Fibrillin-1 Abnormalities in Choctaw Native
Unknown status
- Systemic Sclerosis
-
Houston, TexasUniversity of Texas- Houston Medical School
Jun 23, 2005